[HTML][HTML] Daprodustat for the treatment of anemia in patients not undergoing dialysis
AK Singh, K Carroll, JJV McMurray… - … England Journal of …, 2021 - Mass Medical Soc
Background Daprodustat is an oral hypoxia-inducible factor prolyl hydroxylase inhibitor. In
patients with chronic kidney disease (CKD) who are not undergoing dialysis, the efficacy …
patients with chronic kidney disease (CKD) who are not undergoing dialysis, the efficacy …
Daprodustat for the Treatment of Anemia in Patients Not Undergoing Dialysis
AK SINGH, K CARROLL, S SOLOMON, V JHA… - 2021 - observatorio.fm.usp.br
BACKGROUND Daprodustat is an oral hypoxia-inducible factor prolyl hydroxylase inhibitor.
In patients with chronic kidney disease (CKD) who are not undergoing dialysis, the efficacy …
In patients with chronic kidney disease (CKD) who are not undergoing dialysis, the efficacy …
Daprodustat for the Treatment of Anemia in Patients Not Undergoing Dialysis
AK Singh, K Carroll, JJV McMurray, S Solomon, V Jha… - 2021 - scripta.up.edu.mx
Background: Daprodustat is an oral hypoxia-inducible factor prolyl hydroxylase inhibitor. In
patients with chronic kidney disease (CKD) who are not undergoing dialysis, the efficacy …
patients with chronic kidney disease (CKD) who are not undergoing dialysis, the efficacy …
[PDF][PDF] Daprodustat for the Treatment of Anemia in Patients Not Undergoing Dialysis
AK Singh, JJV McMurray, S Solomon, V Jha… - 2021 - researchgate.net
BACKGROUND Daprodustat is an oral hypoxia-inducible factor prolyl hydroxylase inhibitor.
In patients with chronic kidney disease (CKD) who are not undergoing dialysis, the efficacy …
In patients with chronic kidney disease (CKD) who are not undergoing dialysis, the efficacy …
[引用][C] Daprodustat for the Treatment of Anemia in Patients Not Undergoing Dialysis
AK Singh, K Carroll, JJV McMurray, S Solomon… - New England Journal …, 2021 - elibrary.ru
Daprodustat for the Treatment of Anemia in Patients Not Undergoing Dialysis.
AK Singh, K Carroll, JJV McMurray… - The New England …, 2021 - europepmc.org
Background Daprodustat is an oral hypoxia-inducible factor prolyl hydroxylase inhibitor. In
patients with chronic kidney disease (CKD) who are not undergoing dialysis, the efficacy …
patients with chronic kidney disease (CKD) who are not undergoing dialysis, the efficacy …
Daprodustat for the Treatment of Anemia in Patients Not Undergoing Dialysis
AK Singh, K Carroll, JJ McMurray… - The New England …, 2021 - discovery.ucl.ac.uk
BACKGROUND: Daprodustat is an oral hypoxia-inducible factor prolyl hydroxylase inhibitor.
In patients with chronic kidney disease (CKD) who are not undergoing dialysis, the efficacy …
In patients with chronic kidney disease (CKD) who are not undergoing dialysis, the efficacy …
Daprodustat for the treatment of anemia in patients not undergoing dialysis
AK Singh, K Carroll, JJV Mcmurray, S Solomon… - NEW ENGLAND …, 2021 - iris.unisr.it
BACKGROUND Daprodustat is an oral hypoxia-inducible factor prolyl hydroxylase inhibitor.
In patients with chronic kidney disease (CKD) who are not undergoing dialysis, the efficacy …
In patients with chronic kidney disease (CKD) who are not undergoing dialysis, the efficacy …
Daprodustat for the treatment of anemia in patients not undergoing dialysis
AK Singh, K Carroll, JJV McMurray… - New England Journal …, 2021 - eprints.gla.ac.uk
Background: Daprodustat is an oral hypoxia-inducible factor prolyl hydroxylase inhibitor. In
patients with chronic kidney disease (CKD) who are not undergoing dialysis, the efficacy …
patients with chronic kidney disease (CKD) who are not undergoing dialysis, the efficacy …
[引用][C] Daprodustat for the Treatment of Anemia in Patients Not Undergoing Dialysis
AK Singh, K Carroll, JJV McMurray, S Solomon… - New England Journal …, 2021 - cir.nii.ac.jp
Daprodustat for the Treatment of Anemia in Patients Not Undergoing Dialysis | CiNii Research
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …